SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-22-051105
Filing Date
2022-08-25
Accepted
2022-08-25 16:01:14
Documents
3
Group Members
ALEXANDER LINKDELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTROLF BIRKERTVV BETEILIGUNGEN AKTIENGESELLSCHAFTWILHELM KONRAD THOMAS ZOURS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea164873-13ddeutsc_bio.htm SC 13D 212810
2 JOINT FILING AGREEMENT ea164873ex99-1_bio.htm EX-99.1 6492
3 GRAPHIC image_001.jpg GRAPHIC 26926
  Complete submission text file 0001213900-22-051105.txt   258176
Mailing Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0
Business Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0 49 6221 64727-0
DEUTSCHE BALATON AKTIENGESELLSCHAFT (Filed by) CIK: 0001571071 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Subject) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93395 | Film No.: 221197357
SIC: 2834 Pharmaceutical Preparations